Details

Amélioration du taux de greffe de cellules myogéniques pour la dystrophie musculaire de Duchenne. Surexpression du récepteur à l'IGF-1 sur des cellules humaines et utilisation du facteur de croissance MGF

by Dominique, Jean-Christophe

Abstract (Summary)
Myogenic cells transplantation is one of the promising therapies to treat dystrophic patients. Early cells death and poor migration are important problems who limit this therapy’s success. MGF-Ct24E, a synthetic copy of the peptide E from the IGF-1 Ec isoform, was used. The peptide increases the proliferation of cells and did no effect on the differentiation. Injected systematically and intramuscularly, MGF-Ct24E increased the graft success. When the cells were pretreated with the peptide and co-injected with it, no increase in the graft success was seen. The overexpression of IGF-1 receptor on human cells with a lentivirus increased the proliferation rate and did no effect on their differentiation. When the cells were selected for a high expression of the IGF-1 receptor and for a high phosphorylation of Akt, the graft success was increased. Together, those results are offering an interesting avenue for the amelioration of cells transplantation in DMD.
This document abstract is also available in French.
Document Full Text
The full text for this document is available in French.
Bibliographical Information:

Advisor:Tremblay, Jacques-P.

School:Université Laval

School Location:Canada - Quebec / Québec

Source Type:Master's Thesis

Keywords:médecine

ISBN:

Date of Publication:01/01/2009

© 2009 OpenThesis.org. All Rights Reserved.